Insulin-like growth factor 1 improves the efficacy of mesenchymal stem cells transplantation in a rat model of myocardial infarction

Journal of Biomedical Science

Volumn 15, Issue 1, 2008, Pages 89-97

  Guo, Jun ^a   Lin, Guosheng ^a   Bao, Cuiyu ^b   Hu, Zhimin ^c   Chu, Honggang ^a   Hu, Mingyan ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b HUBEI UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c First Hospital of Wuhan   (China)

Author keywords

Insulin like growth factor 1; Myocardial infarction; Stem cells; Transplantation

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; COLLAGEN; GENE PRODUCT; SOMATOMEDIN C; TNT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY DENSITY; CELL SURFACE; CELL SURVIVAL; CONTROLLED STUDY; FLOW CYTOMETRY; HEART DISEASE; HEART INFARCTION; HEART LEFT VENTRICLE; IN VITRO STUDY; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; CAPILLARIES; CELL SURVIVAL; COLLAGEN; DISEASE MODELS, ANIMAL; INSULIN-LIKE GROWTH FACTOR I; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MYOCARDIAL INFARCTION; RATS; RECEPTORS, CXCR4; TROPONIN T; VENTRICULAR FUNCTION, LEFT;

RATTUS;

EID: 36749001126     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1007/s11373-007-9207-x     Document Type: Article

References (34)

1. Toma C., Pittenger M.F., Cahill K.S., Byrne B.J., Kessler P.D., Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105: 93-98, 2002.
2. Wang J.S., Shum-Tim D., Galipeau J., Chedrawy E., Eliopoulos N., Chiu R.C., Marrow stromal cells for cellular cardiomyoplasty: feasibility and potential clinical advantages. J. Thorac. Cardiovasc. Surg. 120: 999-1005, 2000.
3. Shake J.G., Gruber P.J., Baumgartner W.A., Senechal G., Meyers J., Redmond J.M., Pittenger M.F., Martin B.J., Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann. Thorac. Surg. 73: 1919-1925, 2002.
4. Pouzet B., Vilquin J.T., Hagege A.A., Scorsin M., Messas E., Fiszman M., Schwartz K., Menasche P., Factors affecting functional outcome after autologous skeletal myoblast transplantation. Ann. Thorac. Surg. 71: 844-850, 2001.
5. Kollet O., Spiegel A., Peled A., Petit I., Byk T., Hershkoviz R., Guetta E., Barkai G., Nagler A., Lapidot T., Rapid and efficient homing of human CD34(+)CD38(-/low) CXCR4(+) stem and progenitor cells to the bone marrow and spleen of NOD/SCID and NOD/ SCID/B2m(null) mice. Blood. 97: 3283-3291, 2001.
6. Peled A., Petit I., Kollet O., Magid M., Ponomaryov T., Byk T., Nagler A., Ben-Hur H., Many A., Shultz L., Lider O., Alon R., Zipori D., Lapidot T., Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science. 283: 845-848, 1999.
7. Urbich C., Aicher A., Heeschen C., Dernbach E., Hofmann W.K., Zeiher A.M., Dimmeler S., Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J. Mol. Cell. Cardiol. 39: 733-742, 2005.
8. Xu M., Uemura R., Dai Y., Wang Y., Pasha Z., Ashraf M., In vitro and in vivo effects of bone marrow stem cells on cardiac structure and function. J. Mol Cell Cardiol. 42: 441-448, 2007.
9. Su E.J., Cioffi C.L., Stefansson S., Mittereder N., Garay M., Hreniuk D., Liau G., Gene therapy vector-mediated expression of insulin-like growth factors protects cardiomyocytes from apoptosis and enhances neovascularization. Am. J. Physiol. Heart Circ. Physiol. 284: H1429-H1440, 2003.
10. Li Y., Yu X., Lin S., Li X., Zhang S., Song Y.H., Insulin-like growth factor 1 enhances the migratory capacity of mesenchymal stem cells. Biochem. Biophys. Res. Commun. 356: 780-784, 2007.
11. Nagaya N., Fujii T., Iwase T., Ohgushi H., Itoh T., Uematsu M., Yamagishi M., Mori H., Kangawa K., Kitamura S., Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis. Am. J. Physiol. Heart Circ. Physiol. 287: H2670-H2676, 2004.
12. Barbash I.M., Chouraqui P., Baron J., Feinberg M.S., Etzion S., Tessone A., Miller L., Guetta E., Zipori D., Kedes L.H., Kloner R.A., Leor J., Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation. 108: 863-868, 2003.
13. Chen J., Zhang Z.G., Li Y., Wang L., Xu Y.X., Gautam S.C., Lu M., Zhu Z., Chopp M., Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats. Circ. Res. 92: 692-699, 2003.
14. Askari A.T., Unzek S., Popovic Z.B., Goldman C.K., Forudi F., Kiedrowski M., Rovner A., Ellis S.G., Thomas J.D., DiCorleto P.E., Topol E.J., Penn M.S., Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 362: 697-703, 2003.
15. Pillarisetti K., Gupta S.K., Cloning and relative expression analysis of rat stromal cell derived factor-1 (SDF-1)1: SDF-1 alpha mRNA is selectively induced in rat model of myocardial infarction. Inflammation 25: 293-300, 2001.
16. Hiasa K., Ishibashi M., Ohtani K., Inoue S., Zhao Q., Kitamoto S., Sata M., Ichiki T., Takeshita A., Egashira K., Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization. Circulation 109: 2454-2461, 2004.
17. Askari A.T., Unzek S., Popovic Z.B., Goldman C.K., Forudi F., Kiedrowski M., Rovner A., Ellis S.G., Thomas J.D., DiCorleto P.E., Topol E.J., Penn M.S., Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 362: 697-703, 2003.
18. Abbott J.D., Huang Y., Liu D., Hickey R., Krause D.S., Giordano F.J., Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 110: 3300-3305, 2004.
19. Ma J., Ge J., Zhang S., Sun A., Shen J., Chen L., Wang K., Zou Y., Time course of myocardial stromal cell-derived factor 1 expression and beneficial effects of intravenously administered bone marrow stem cells in rats with experimental myocardial infarction. Basic Res Cardiol. 100: 217-223, 2005.
20. Hattori K., Heissig B., Tashiro K., Honjo T., Tateno M., Shieh J.H., Hackett N.R., Quitoriano M.S., Crystal R.G., Rafii S., Moore M.A., Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. Blood 97: 3354-3360, 2001.
21. Moore M.A., Hattori K., Heissig B., Shieh J.H., Dias S., Crystal R.G., Rafii S., Mobilization of endothelial and hematopoietic stem and progenitor cells by adenovector-mediated elevation of serum levels of SDF-1, VEGF, and angiopoietin-1. Ann. N.Y. Acad. Sci. 938: 36-45, 2001.
22. Elmadbouh I., Haider H.Kh., Jiang S., Idris N.M., Lu G., Ashraf M. Ex vivo delivered stromal cell-derived factor-1α promotes stem cell homing and induces angiomyogenesis in the infarcted myocardium. J. Mol. Cell. Cardiol. 42: 792-803, 2007.
23. Petit I., Szyper-Kravitz M., Nagler A., Lahav M., Peled A., Habler L., Ponomaryov T., Taichman R.S., Arenzana-Seisdedos F., Fujii N., Sandbank J., Zipori D., Lapidot T., G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat. Immunol. 3: 687-694, 2002.
24. Kahn J., Byk T., Jansson-Sjostrand L., Petit I., Shivtiel S., Nagler A., Hardan I., Deutsch V., Gazit Z., Gazit D., Karlsson S., Lapidot T., Overexpression of CXCR4 on human CD34+ progenitors increases their proliferation, migration, and NOD/SCID repopulation. Blood 103: 2942-2949, 2004.
25. Bhakta S., Hong P., Koc O., The surface adhesion molecule CXCR4 stimulates mesenchymal stem cell migration to stromal cell-derived factor-1 in vitro but does not decrease apoptosis under serum deprivation. Cardiovasc. Revasc. Med. 7: 19-24, 2006.
26. Ambler G.R., Johnston B.M., Maxwell L., Gavin J.B., Gluckman P.D., Improvement of doxorubicin induced cardiomyopathy in rats treated with insulin-like growth factor I. Cardiovasc. Res. 27: 1368-1373, 1993.
27. Duerr R.L., McKirnan M.D., Gim R.D., Clark R.G., Chien K.R., Ross J. Jr., Cardiovascular effects of insulin-like growth factor-1 and growth hormone in chronic left ventricular failure in the rat. Circulation 93: 2188-2196, 1996.
28. Kinugawa S., Tsutsui H., Ide T., Nakamura R., Arimura K., Egashira K., Takeshita A., Positive inotropic effect of insulin-like growth factor-1 on normal and failing cardiac myocytes. Cardiovasc. Res. 43: 157-164, 1999.
29. Li G., Borger M.A., Williams W.G., Weisel R.D., Mickle D.A., Wigle E.D., Li R.K., Regional overexpression of insulin-like growth factor-I and transforming growth factor-beta1 in the myocardium of patients with hypertrophic obstructive cardiomyopathy. J. Thorac. Cardiovasc. Surg. 123: 89-95, 2002.
30. Li Q., Li B., Wang X., Leri A., Jana K.P., Liu Y., Kajstura J., Baserga R., Anversa P., Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy. J. Clin. Invest. 100: 1991-1999, 1997.
31. Redaelli G., Malhotra A., Li B., Li P., Sonnenblick E.H., Hofmann P.A., Anversa P., Effects of constitutive overexpression of insulin-like growth factor-1 on the mechanical characteristics and molecular properties of ventricular myocytes. Circ. Res. 82: 594-603, 1998.
32. Ross J. Jr. Growth hormone, cardiomyocyte contractile reserve, and heart failure. Circulation 99: 15-17, 1999.
33. Welch S., Plank D., Witt S., Glascock B., Schaefer E., Chimenti S., Andreoli A.M., Limana F., Leri A., Kajstura J., Anversa P., Sussman M.A., Cardiac-specific IGF-1 expression attenuates dilated cardiomyopathy in tropomodulin-overexpressing transgenic mice. Circ. Res. 90: 641-648, 2002.
34. Kofidis T., de Bruin J.L., Yamane T., Balsam L.B., Lebl D.R., Swijnenburg R.J., Tanaka M., Weissman I.L., Robbins R.C., Insulin-like growth factor promotes engraftment, differentiation, and functional improvement after transfer of embryonic stem cells for myocardial restoration. Stem Cells 22: 1239-1245, 2004.